130 results
Page 6 of 7
6-K
EX-99.3
j93qn
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
phnswbn xfq1s
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.2
xab7h3m
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
529wyk8snohc5
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
3rqvmvgl
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.6
ccvfxrcv 9d
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
12q4fl jr7ptnh
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
7qm4 y0o7u
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
6-K
EX-99.1
df16zynj
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
5rvppx
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
chl295rgenla n8xe
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
EX-5.1
suf2s5lbo04ptkweh6wb
8 Jan 21
Registration statement (foreign)
4:58pm
F-1
igk5wusim6tlkg
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
kn66ghtelg 00
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
vb196etjs8a9
17 Dec 20
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
6:15am
6-K
mwgwytvqz8sx
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
rqo83p yz2oq9dokd9rs
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.1
t1ov rh6j9rr3m
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
EX-99.1
fcfmd3ea2
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
x9ridnyhs7jn lh348a
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am